Do targeted drugs go into medical insurance, and do targeted drugs go through medical insurance?

At present, many anti-cancer drugs are included in medical insurance, which mainly means that most of the chemotherapy drugs are included in the medical insurance (of course, there are still a small number of the latest chemotherapy drugs that are not included in the medical insurance), and most targeted drugs have not been included in the medical insurance. However, more and more targeted drugs have begun to be included in the medical insurance, but the provinces and cities are different, some enter the medical insurance earlier, some later medical insurance, some have a higher reimbursement ratio, and some have a lower reimbursement ratio. Whether you can enter the medical insurance or not, and how high the reimbursement ratio of the medical insurance is, is mainly a matter for the medical insurance department, and the doctor has no right to decide.

The targeted drugs included in the medical insurance this time are: multi-target anti-angiogenic targeted drug lenvatinib, EGFR-targeted drugs osimertinib and ametinib, ovarian cancer targeted drug niraparib, bone metastasis control targeted drug denosumab, trametinib, dabrafenib, etc. Next, let's take a closer look at the approved targeted drugs for various cancer types.

Non-small cell lung cancer: gefitinib, erlotinib, icotinib, afatinib, osimertinib, ametinib, anlotinib, crizotinib, ceritinib, alectinib, bevacizumab, recombinant human endothelial inhibitors.

Colorectal cancer: cetuximab, bevacizumab, regorafenib, fruquintinib.

Gastrointestinal stromal tumors: regorafenib, imatinib, sunitinib.

Gastric cancer and gastroesophageal junction adenocarcinoma: trastuzumab, apatinib.

Renal cell carcinoma: pazopanib, axitinib, sorafenib, everolimus, sunitinib.

Neuroendocrine tumors: everolimus, sunitinib.

Breast cancer: trastuzumab, initumab, pertuzumab, pyrotinib, fulvestrant.

Ovarian, fallopian tube, or primary peritoneal cancer: olaparib, niraparib.

Prostate cancer: enzalutamide, abiraterone.

Hepatocellular carcinoma: regorafenib, sorafenib, lenvatinib.

Thyroid cancer: sorafenib.

Nasopharyngeal carcinoma: Nimotuzumab.

Melanoma: vemurafenib, trametinib, dabrafenib.

Subependymal giant cell astrocytoma: everolimus.

Renal angiomyolipoma: everolimus.

Hematologic malignancies: imatinib, dasatinib, flumatinib, nilotinib, ibrutinib, zanubrutinib, ruxolitinib, azacitidine, rituximab, chidamide, bortezomib.

As long as it is a targeted drug that is included in the medical insurance, all provinces have implemented access to the local medical insurance system directory. Targeted drugs are included in social security, so that many patients who cannot afford drugs** cancer can see the hope of survival again. At present, the cost of anti-cancer drugs added to the social security list is part of the social security reimbursement, and part of it is paid by oneself, which will gradually reduce the drug burden of cancer patients.

OK.

The National Healthcare Security Administration has included 17 anti-cancer drugs in the scope of Class B of the National Basic Medical Insurance, Work-related Injury Insurance and Maternity Insurance Drug Catalogue, including: azacitidine, cetuximab, afatinib, etc.

Legal basis: Social Insurance Law of the People's Republic of China

Article 2 The State shall establish a social insurance system of basic endowment insurance, basic medical insurance, work-related injury insurance, unemployment insurance, maternity insurance, and so on, to ensure citizens' right to receive material assistance from the State and society in accordance with the law in the event of old age, illness, work-related injury, unemployment, childbirth, and so forth.

Article 26 The standards for the treatment of basic medical insurance for workers, new rural cooperative medical care, and basic medical insurance for urban residents shall be implemented in accordance with state regulations. Article 28 In line with the basic medical insurance drug list, diagnosis and treatment items, medical service facility standards and emergency and rescue medical expenses, in accordance with the provisions of the state from the basic medical insurance ** payment.

Legal analysis: Targeted drugs can be taken by medical insurance, and after targeted drugs are included in the medical insurance, they are basically class B drugs, and the price of drugs is greatly reduced, and the people only need to bear 20% and 30% of the cost after self-payment.

Legal basis: Article 28 of the Social Insurance Law of the People's Republic of China Article 28 Medical expenses that meet the standards of basic medical insurance drug lists, diagnosis and treatment items, medical service facilities, and emergency and rescue shall be paid from the basic medical insurance in accordance with national regulations.

Summary. Hello, Legal Analysis: Whether Targeted Drugs Are Included in Medical Insurance:

Yes, some targeted** drugs are covered by medical insurance, but not all targeted drugs are reimbursable. For example, first-line targeted drugs for lung cancer, including Iressa and Sarot, can be applied for a certain amount of reimbursement as special drugs. Herceptin, a commonly used targeted drug for breast cancer, is also included in the scope of medical insurance reimbursement in most provinces.

There are also many oral targeted drugs for gastric cancer, such as apatinib, which have now been included in the scope of medical insurance reimbursement. However, the types of targeted drugs included in the reimbursement are also different in different provinces and regions. ** If you want to go to the medical insurance department of your local hospital for a detailed consultation, you can also consult a doctor.

Each region has a list of drugs, and you can check whether the targeted drugs you use are covered by medical insurance.

Hello, legal analysis: whether targeted drugs are included in medical insurance: Yes, some targeted drugs are within the scope of medical insurance reimbursement, but not all targeted drugs can be reimbursed.

For example, first-line targeted drugs for lung cancer, including Iressa, Sarote, and pants can be applied for a certain reimbursement amount as special drugs. Herceptin, a commonly used targeted drug for breast cancer, is also included in the scope of medical insurance reimbursement in most provinces. There are also many oral targeted drugs for gastric cancer, such as apatinib, which have now been included in the scope of medical insurance reimbursement.

However, the types of targeted drugs included in the reimbursement are also different in different provinces and regions. ** When you go, you can go to the medical insurance department of the local hospital for a detailed consultation, or you can consult a doctor. Each region has a list of drugs, and you can check whether the targeted drugs you use are covered by medical insurance.

Legal basis: The current targeted drugs used for ** lung cancer can be divided into the following types. 1.

Human epidermal growth factor receptor tyrosine kinase inhibitors, mainly including gefitinib, erlotinib, afatinib, dacotinib, osimertinib. Among them, gefitinib, erlotinib, afatinib and osimertinib are drugs in the national orange pomace medical insurance list. 2.

Anaplastic lymphoma kinase tyrosine kinase inhibitors, including crizotinib, ceritinib, alectinib, brigatinib, lorlatinib. Among them, crizotinib and alectinib are drugs in the national medical insurance list. Forward bend 3

Vascular endothelial growth factor (receptor) monoclonal antibodies or fusion protein drugs, such as bevacizumab and ranibizumab. Both are drugs in the national medical insurance list. 4.

Other targeted drugs for lung cancer include dabrafenib, vemurafenib, trametinib, larotrectinib, entrectinib, etc.